Figure 4
From: Replacement of the C6ORF66 Assembly Factor (NDUFAF4) Restores Complex I Activity in Patient Cells
Effect of TAT-ORF fusion protein on patients’ cell viability. F528 cells were incubated with TAT-ORF (0.02 µg/µL final concentration; however, at different start concentrations) for 24 h (A) or 48 h (B), and cell viability was measured. Results are expressed as percentage of proliferation (untreated cells being 100%) and are the mean of triplicates ± SD. *p < 0.05.